Compounded BriefA Women's Health Briefing for Busy Moms
Scam Watch · Safety Investigation

Parking-Lot Pharmacists: What Whistleblowers Say Was Happening at a GLP-1 Supplier

Untrained workers recruited from hardware-store parking lots. Vials that broke and left glass in the product. A state notice warning of risk of “serious injury, serious impairment, or death.” Here's what the reporting shows — and how to make sure your medication never comes from a place like this.

I spent years working in a compounding pharmacy, and I want to tell you what “normal” looks like there: gowning procedures. Lot numbers. A pharmacist who checks the math twice and signs their name to it. The job is repetitive on purpose, because repetition is what keeps a sterile drug sterile.

Now let me tell you what whistleblowers say was happening at a pharmacy supplying compounded GLP-1 medications to a fast-growing weight-loss telehealth — because the gap between those two pictures is the entire reason this site exists.

What the reporting found

According to an investigation by NBC Bay Area, multiple employees of Aequita Pharmacy — a Kirkland, Washington supplier that worked with San Francisco weight-loss startup Mochi Health — went to state inspectors in 2025 with a long list of patient-safety allegations. Among them:

When Washington Department of Health inspectors showed up unannounced in March 2025, they found unlicensed peptide powders in a warehouse refrigerator — and issued a Notice of Immediate Jeopardy, the regulatory equivalent of pulling a fire alarm. Their words, per the reporting: the pharmacy's deficient practices “have placed the health and safety of individuals at risk of serious injury, serious impairment, or death.”

Aequita closed in April 2025. KING 5's companion investigation in Washington reported the same pattern: day laborers, contaminated vials, a pharmacy moving too fast to be careful. Both Aequita and Mochi's CEO declined to comment when NBC reporters asked; these remain allegations from whistleblowers and findings described in the state's notice, and Mochi continues to offer compounded GLP-1s through other pharmacies nationwide.

Why I'm telling you this

Not to scare you off compounded medication — I take it myself. I'm telling you because this story is the clearest case I've seen for the single most boring question in my provider checklist: which pharmacy fills your prescription?

Here's the thing about the women ordering from that telehealth: they did nothing wrong. The website was polished. The price was good. The medication showed up in the mail like it was supposed to. Every visible part of the experience looked fine — because everything that was allegedly going wrong happened at a pharmacy two states away that most customers couldn't have named.

That's the uncomfortable lesson. You cannot judge a compounding operation by the website that sells you the prescription. The only protection you have is knowing who the pharmacy is — and checking.

What I'd do this week if you're on a compounded GLP-1

The bottom line

The pharmacy is the product

The prescription is paperwork; the pharmacy is what actually ends up in the syringe. Whistleblowers allege one supplier treated that responsibility like a side hustle — and the state's own inspectors used the words “serious injury, serious impairment, or death.” Know your pharmacy's name. Verify its license. And if a provider won't tell you, close the tab.

Sources

A note on fairness: the allegations above come from whistleblowers and state inspection findings as described in the linked reporting; the companies involved declined to comment to reporters. Medical disclaimer: The Compounded Brief is not a pharmacy, prescriber, or medical provider, and nothing here is medical advice. Compounded medications are not FDA-approved; obtain them only from a licensed compounding pharmacy after evaluation by a licensed provider. Talk to a licensed professional before starting, stopping, or changing any medication.